Plus Therapeutics Boosted by $1.6 Million Advance Payment from CPRIT

PLUS Therapeutics, Inc. shares are trading higher after announcing a $1.6 million advance payment from CPRIT as part of a $17.6 million grant to support clinical development of its CNS cancer treatments.